Biocardiainc Stock Operating Margin

BCDA Stock  USD 0.42  0.01  2.44%   
BiocardiaInc fundamentals help investors to digest information that contributes to BiocardiaInc's financial success or failures. It also enables traders to predict the movement of BiocardiaInc Stock. The fundamental analysis module provides a way to measure BiocardiaInc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BiocardiaInc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

BiocardiaInc Operating Margin Analysis

BiocardiaInc's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
 2021 2022 2023 2024 (projected)
Interest Expense9K6K6.9K6.6K
Depreciation And Amortization67K82K94.3K89.6K

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current BiocardiaInc Operating Margin

    
  (7.28) %  
Most of BiocardiaInc's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BiocardiaInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

BiocardiaInc Operating Margin Driver Correlations

Understanding the fundamental principles of building solid financial models for BiocardiaInc is extremely important. It helps to project a fair market value of BiocardiaInc Stock properly, considering its historical fundamentals such as Operating Margin. Since BiocardiaInc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of BiocardiaInc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of BiocardiaInc's interrelated accounts and indicators.
-0.180.93-0.95-0.1-0.040.150.360.15-0.070.990.50.470.130.18-0.240.130.160.490.090.03-0.09-0.070.630.61-0.02
-0.18-0.470.46-0.870.57-0.020.580.870.97-0.3-0.75-0.40.78-0.53-0.42-0.730.130.510.90.930.870.82-0.34-0.38-0.91
0.93-0.47-0.980.22-0.30.170.15-0.15-0.380.970.70.41-0.20.2-0.140.390.10.28-0.21-0.27-0.35-0.390.720.730.28
-0.950.46-0.98-0.190.19-0.18-0.190.150.36-0.98-0.66-0.530.14-0.330.06-0.33-0.12-0.310.20.280.390.33-0.69-0.7-0.26
-0.1-0.870.22-0.19-0.70.07-0.53-0.97-0.950.020.590.11-0.880.40.520.76-0.12-0.56-0.97-0.89-0.85-0.90.310.360.83
-0.040.57-0.30.19-0.7-0.220.410.610.63-0.1-0.510.120.64-0.05-0.19-0.78-0.190.320.610.450.350.8-0.41-0.43-0.46
0.15-0.020.17-0.180.07-0.220.16-0.07-0.090.17-0.2-0.090.130.070.220.10.330.630.00.06-0.17-0.060.570.56-0.07
0.360.580.15-0.19-0.530.410.160.50.520.31-0.310.110.54-0.05-0.21-0.330.280.690.520.50.290.470.170.14-0.53
0.150.87-0.150.15-0.970.61-0.070.50.940.02-0.53-0.240.82-0.58-0.67-0.710.110.560.980.90.870.86-0.25-0.3-0.82
-0.070.97-0.380.36-0.950.63-0.090.520.94-0.19-0.69-0.30.84-0.52-0.5-0.770.110.50.960.950.910.88-0.36-0.4-0.91
0.99-0.30.97-0.980.02-0.10.170.310.02-0.190.570.480.010.22-0.180.220.150.43-0.03-0.1-0.22-0.180.670.660.1
0.5-0.750.7-0.660.59-0.51-0.2-0.31-0.53-0.690.570.35-0.740.270.050.59-0.01-0.39-0.58-0.63-0.58-0.750.270.30.62
0.47-0.40.41-0.530.110.12-0.090.11-0.24-0.30.480.35-0.020.80.230.31-0.040.01-0.28-0.31-0.37-0.050.010.020.21
0.130.78-0.20.14-0.880.640.130.540.820.840.01-0.74-0.02-0.19-0.28-0.710.150.690.840.790.720.89-0.06-0.11-0.75
0.18-0.530.2-0.330.4-0.050.07-0.05-0.58-0.520.220.270.8-0.190.760.270.03-0.11-0.55-0.55-0.61-0.320.140.160.41
-0.24-0.42-0.140.060.52-0.190.22-0.21-0.67-0.5-0.180.050.23-0.280.760.090.09-0.19-0.58-0.55-0.58-0.440.190.210.44
0.13-0.730.39-0.330.76-0.780.1-0.33-0.71-0.770.220.590.31-0.710.270.09-0.14-0.37-0.77-0.59-0.55-0.730.260.290.56
0.160.130.1-0.12-0.12-0.190.330.280.110.110.15-0.01-0.040.150.030.09-0.140.210.250.05-0.010.070.190.18-0.05
0.490.510.28-0.31-0.560.320.630.690.560.50.43-0.390.010.69-0.11-0.19-0.370.210.580.590.360.490.480.43-0.57
0.090.9-0.210.2-0.970.610.00.520.980.96-0.03-0.58-0.280.84-0.55-0.58-0.770.250.580.90.860.87-0.24-0.29-0.82
0.030.93-0.270.28-0.890.450.060.50.90.95-0.1-0.63-0.310.79-0.55-0.55-0.590.050.590.90.940.78-0.22-0.27-0.97
-0.090.87-0.350.39-0.850.35-0.170.290.870.91-0.22-0.58-0.370.72-0.61-0.58-0.55-0.010.360.860.940.72-0.35-0.4-0.87
-0.070.82-0.390.33-0.90.8-0.060.470.860.88-0.18-0.75-0.050.89-0.32-0.44-0.730.070.490.870.780.72-0.39-0.43-0.73
0.63-0.340.72-0.690.31-0.410.570.17-0.25-0.360.670.270.01-0.060.140.190.260.190.48-0.24-0.22-0.35-0.391.00.25
0.61-0.380.73-0.70.36-0.430.560.14-0.3-0.40.660.30.02-0.110.160.210.290.180.43-0.29-0.27-0.4-0.431.00.29
-0.02-0.910.28-0.260.83-0.46-0.07-0.53-0.82-0.910.10.620.21-0.750.410.440.56-0.05-0.57-0.82-0.97-0.87-0.730.250.29
Click cells to compare fundamentals
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

BiocardiaInc Pretax Profit Margin

Pretax Profit Margin

(10.63)

At present, BiocardiaInc's Pretax Profit Margin is projected to drop based on the last few years of reporting.
Based on the recorded statements, BiocardiaInc has an Operating Margin of -7.2773%. This is 79.26% lower than that of the Biotechnology sector and 93.51% lower than that of the Health Care industry. The operating margin for all United States stocks is 32.07% higher than that of the company.

BiocardiaInc Operating Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BiocardiaInc's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BiocardiaInc could also be used in its relative valuation, which is a method of valuing BiocardiaInc by comparing valuation metrics of similar companies.
BiocardiaInc is currently under evaluation in operating margin category among related companies.

BiocardiaInc Fundamentals

About BiocardiaInc Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze BiocardiaInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BiocardiaInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BiocardiaInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart and Morph deflectable guides and sheaths. Biocardia operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 28 people.

Pair Trading with BiocardiaInc

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BiocardiaInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BiocardiaInc will appreciate offsetting losses from the drop in the long position's value.

Moving together with BiocardiaInc Stock

  0.77MBRX Moleculin Biotech Upward RallyPairCorr
  0.79MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr

Moving against BiocardiaInc Stock

  0.82DNTH Dianthus Therapeutics Symbol ChangePairCorr
  0.74MGNX MacroGenics Financial Report 14th of May 2024 PairCorr
  0.72MRK Merck Company Fiscal Quarter End 31st of March 2024 PairCorr
  0.65MDWD Mediwound Financial Report 4th of June 2024 PairCorr
  0.62EQ Equillium Financial Report 9th of May 2024 PairCorr
The ability to find closely correlated positions to BiocardiaInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BiocardiaInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BiocardiaInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BiocardiaInc to buy it.
The correlation of BiocardiaInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BiocardiaInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BiocardiaInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BiocardiaInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether BiocardiaInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BiocardiaInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biocardiainc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biocardiainc Stock:
Check out BiocardiaInc Piotroski F Score and BiocardiaInc Altman Z Score analysis.
For information on how to trade BiocardiaInc Stock refer to our How to Trade BiocardiaInc Stock guide.
Note that the BiocardiaInc information on this page should be used as a complementary analysis to other BiocardiaInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for BiocardiaInc Stock analysis

When running BiocardiaInc's price analysis, check to measure BiocardiaInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BiocardiaInc is operating at the current time. Most of BiocardiaInc's value examination focuses on studying past and present price action to predict the probability of BiocardiaInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BiocardiaInc's price. Additionally, you may evaluate how the addition of BiocardiaInc to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Is BiocardiaInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BiocardiaInc. If investors know BiocardiaInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BiocardiaInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.62)
Revenue Per Share
0.028
Quarterly Revenue Growth
0.684
Return On Assets
(1.22)
Return On Equity
(7.29)
The market value of BiocardiaInc is measured differently than its book value, which is the value of BiocardiaInc that is recorded on the company's balance sheet. Investors also form their own opinion of BiocardiaInc's value that differs from its market value or its book value, called intrinsic value, which is BiocardiaInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BiocardiaInc's market value can be influenced by many factors that don't directly affect BiocardiaInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BiocardiaInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if BiocardiaInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BiocardiaInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.